The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Clinical implications of mucosal healing for the management of IBD
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Self-citationInfliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Self-citationNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
Daperno, M., D'Haens, G., Van Assche, G., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,774
Self-citationSeverity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
D'Haens, G., Baert, F., van Assche, G., Caenepeel, P., Vergauwe, P., Tuynman, H., De Vos, M., van Deventer, S., Stitt, L., Donner, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60304-9 · Cited by 1,231
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., Lémann, M., Marteau, P., Rutgeerts, P., Schölmerich, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.038 · Cited by 1,207
Self-citationMucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Rachmilewitz, D. (1989) · BMJ · doi:10.1136/bmj.298.6666.82 · Cited by 1,039
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
Rutgeerts, P., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.014 · Cited by 943
Self-citationNatalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Self-citationMethotrexate for the Treatment of Crohn's Disease
Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 911
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.
Rutgeerts, P., Geboes, K., Vantrappen, G., Kerremans, R., Coenegrachts, J. L., & Coremans, G. (1984) · Gut · doi:10.1136/gut.25.6.665 · Cited by 787
Gupta, R. B., Harpaz, N., Itzkowitz, S., Hossain, S., Matula, S., Kornbluth, A., Bodian, C., & Ullman, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.001 · Cited by 786
D'Haens, G., Van Deventer, S., Van Hogezand, R., Chalmers, D., Kothe, C., Baert, F., Braakman, T., Schaible, T., Geboes, K., & Rutgeerts, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70005-3 · Cited by 745
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
Modigliani, R., Mary, J.-Y., Simon, J.-F., Cortot, A., Soule, J.-C., Gendre, J.-P., & Rene, E. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90002-i · Cited by 699
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Dubé, R., Cohen, A., Steinhart, A. H., Landau, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042982 · Cited by 692
Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Lochs, H., Löfberg, R., Modigliani, R., Present, D. H., Rutgeerts, P., Schölmerich, J., Stange, E. F., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31072 · Cited by 686
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T., Sparr, J., Prokipchuk, E., & Borgen, L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90621-4 · Cited by 677
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease
Rimola, J., Rodriguez, S., García-Bosch, O., Ordás, I., Ayala, E., Aceituno, M., Pellisé, M., Ayuso, C., Ricart, E., Donoso, L., et al. (2009) · Gut · doi:10.1136/gut.2008.167957 · Cited by 675
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
Schnitzler, F., Fidder, H., Ferrante, M., Noman, M., Arijs, I., Van Assche, G., Hoffman, I., Van Steen, K., Vermeire, S., & Rutgeerts, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20927 · Cited by 673
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Variation Between Observers in Describing Mucosal Appearances in Proctocolitis
Baron, J. H., Connell, A. M., & Lennard-Jones, J. E. (1964) · BMJ · doi:10.1136/bmj.1.5375.89 · Cited by 611
Enteral nutritional therapy for induction of remission in Crohn's disease
Zachos, M., Tondeur, M., & Griffiths, A. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub2 · Cited by 598
Travis, S. P. L., Stange, E. F., Lémann, M., Öresland, T., Chowers, Y., Forbes, A., D’Haens, G., Kitis, G., Cortot, A., Prantera, C., et al. (2006) · Gut · doi:10.1136/gut.2005.081950b · Cited by 597
Self-citationMicroscopic activity in ulcerative colitis: what does it mean?
Riley, S. A., Mani, V, Goodman, M. J., Dutt, S., & Herd, M. E. (1991) · Gut · doi:10.1136/gut.32.2.174 · Cited by 564
INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS
Truelove, S. C., & Jewell, D. P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90552-2 · Cited by 549
Rutgeerts, P., Diamond, R. H., Bala, M., Olson, A., Lichtenstein, G. R., Bao, W., Patel, K., Wolf, D. C., Safdi, M., Colombel, J. F., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2005.08.011 · Cited by 548
Self-citationPodolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110033251406 · Cited by 541
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1954) · BMJ · doi:10.1136/bmj.2.4884.375 · Cited by 538
Ardizzone, S., Maconi, G., Russo, A., Imbesi, V, Colombo, E., & Bianchi Porro, G. (2006) · Gut · doi:10.1136/gut.2005.068809 · Cited by 505
Disease Activity Courses in a Regional Cohort of Crohn's Disease Patients
Munkholm, P., Langholz, E., Davidsen, M., & Binder, V. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096316 · Cited by 501
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Bitton, A., Peppercorn, M. A., Antonioli, D. A., Niles, J. L., Shah, S., Bousvaros, A., Ransil, B., Wild, G., Cohen, A., Deb Edwardes, M. D., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20912 · Cited by 490
Kozarek, R. A., Patterson, D. J., Gelfand, M. D., Botoman, V. A., Ball, T. J., & Wilske, K. R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-5-353 · Cited by 488
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Borrelli, O., Cordischi, L., Cirulli, M., Paganelli, M., Labalestra, V., Uccini, S., Russo, P. M., & Cucchiara, S. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.010 · Cited by 471
Van Assche, G., D’haens, G., Noman, M., Vermeire, S., Hiele, M., Asnong, K., Arts, J., D’hoore, A., Penninckx, F., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 448
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2004) · Gut · doi:10.1136/gut.2003.038505 · Cited by 442
Fell, Paintin, Arnaud‐Battandier, Beattie, Hollis, Kitching, Donnet‐Hughes, Macdonald, & Walker‐Smith (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00707.x · Cited by 407
D'Haens, G., Lemmens, L., Nevens, F., Hiele, M., Rutgeerts, P., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Van Acker, F., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 393
Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
Kamm, M. A., Sandborn, W. J., Gassull, M., Schreiber, S., Jackowski, L., Butler, T., Lyne, A., Stephenson, D., Palmen, M., & Joseph, R. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.011 · Cited by 352
Lémann, M., Mary, J.-Y., Colombel, J.-F., Duclos, B., Soule, J.-C., Lerebours, E., Modigliani, R., & Bouhnik, Y. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.031 · Cited by 349
Self-citationA Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis
Powell-Tuck, J., Bown, R. L., & Lennard-Jones, J. E. (1978) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527809182199 · Cited by 335
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Renzulli, P., & Seibold, F. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20986 · Cited by 326
Hanauer, S. B., Sandborn, W. J., Kornbluth, A., Katz, S., Safdi, M., Woogen, S., Regalli, G., Yeh, C., Smith-Hall, N., & Ajayi, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00248.x · Cited by 322
Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?
Rutgeerts, P., Vermeire, S., & Van Assche, G. (2007) · Gut · doi:10.1136/gut.2005.088732 · Cited by 321
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
Marshall, J. K., & Irvine, E. J. (1997) · Gut · doi:10.1136/gut.40.6.775 · Cited by 314
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
Hellers, G., Cortot, A., Jewell, D., Leijonmarck, C. E., Löfberg, R., Malchow, H., Nilsson, L.-G., Pallone, F., Pena, S., Persson, T., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70125-3 · Cited by 295
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Lichtenstein, G. R., Kamm, M. A., Boddu, P., Gubergrits, N., Lyne, A., Butler, T., Lees, K., Joseph, R. E., & Sandborn, W. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.025 · Cited by 267
Hanauer, S., SCHWARTZ, J., ROBINSON, M. G., Roufail, W. M., Arora, S., Cello, J. P., & Safdi, M. A. (1993) · PubMed · Cited by 266
Allez, M., Lemann, M., Bonnet, J., Cattan, P., Jian, R., & Modigliani, R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05614.x · Cited by 263
Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease
D'Haens, G., Geboes, K., Ponette, E., Penninckx, F., & Rutgeerts, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70027-1 · Cited by 246
Importance of mucosal healing in ulcerative colitis
Lichtenstein, G. R., & Rutgeerts, P. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20997 · Cited by 239
Long-term outcome after infliximab for refractory ulcerative colitis
Ferrante, M., Vermeire, S., Fidder, H., Schnitzler, F., Noman, M., Van Assche, G., De Hertogh, G., Hoffman, I., D'Hoore, A., Van Steen, K., et al. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2008.03.004 · Cited by 223
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine
D'Haens, G., Geboes, K., & Rutgeerts, P. (1999) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(99)80017-0 · Cited by 216
Crohn's disease: monitoring disease activity
Sostegni, R., Daperno, M., Scaglione, N., Lavagna, A., Rocca, R., & Pera, A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.17.s2.17.x · Cited by 208
Kruis, W., Kiudelis, G., Racz, I., Gorelov, I. A., Pokrotnieks, J., Horynski, M., Batovsky, M., Kykal, J., Boehm, S., Greinwald, R., et al. (2009) · Gut · doi:10.1136/gut.2008.154302 · Cited by 204
Lofberg, R., Danielsson, A., Suhr, O., Nilsson, A., Schioler, R., Nyberg, A., Hultcrantz, R., Kollberg, B., Gillberg, R., Willen, R., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964395 · Cited by 189
Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease
Baldassano, R. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00007-8 · Cited by 179
Hanauer, S. B., Robinson, M., Pruitt, R., Lazenby, A. J., Persson, T., Nilsson, L., Walton–Bowen, K., Haskell, L. P., & Levine, J. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70131-3 · Cited by 179
Kamm, M. A., Lichtenstein, G. R., Sandborn, W. J., Schreiber, S., Lees, K., Barrett, K., & Joseph, R. (2008) · Gut · doi:10.1136/gut.2007.138248 · Cited by 176
SANDBORN, W. J., KAMM, M. A., LICHTENSTEIN, G. R., LYNE, A., BUTLER, T., & JOSEPH, R. E. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03361.x · Cited by 168
Borrelli, O., Bascietto, C., Viola, F., Bueno de Mesquita, M., Barbato, M., Mancini, V., Bosco, S., & Cucchiara, S. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2003.12.014 · Cited by 167
Influence of treatment on morphological features of mucosal inflammation
Geboes, K., & Dalle, I. (2002) · Gut · doi:10.1136/gut.50.suppl_3.iii37 · Cited by 166
Hanauer, S. B., Sandborn, W. J., Dallaire, C., Archambault, A., Yacyshyn, B., Yeh, C., & Smith-Hall, N. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/862917 · Cited by 164
Enteral nutrition for maintenance of remission in Crohn's disease
Akobeng, A. K., & Thomas, A. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005984.pub2 · Cited by 160
Mantzaris, G. J., Christidou, A., Sfakianakis, M. E., Roussos, A., Koilakou, S., Petraki, K., & Polyzou, P. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20777 · Cited by 158
Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice
Fefferman, D. S., & Farrell, R. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00441-0 · Cited by 153
Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis
Carbonnel, Gargouri, Lémann, M., Beaugerie, Cattan, Cosnes, & Gendre (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00705.x · Cited by 139
Self-citationRizzello, F., Gionchetti, P., D’Arienzo, A., Manguso, F., Matteo, G. D., Annese, V., Valpiani, D., Casetti, T., Adamo, S., Prada, A., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01298.x · Cited by 130
Regueiro, M. D., Loftus, E. V., Steinhart, H., & Cohen, R. D. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231495.92013.5e · Cited by 128
Afif, W., Leighton, J. A., Hanauer, S. B., Loftus, E. V., Faubion, W. A., Pardi, D. S., Tremaine, W. J., Kane, S. V., Bruining, D. H., Cohen, R. D., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20924 · Cited by 128
Geboes, K., Rutgeerts, P. J., Opdenakker, G., Olson, A. D., Patel, K., Wagner, C. L., & Marano, C. W. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65457 · Cited by 125
Afzal, N. A., van der Zaag–Loonen, H. J., Arnaud‐Battandier, F., Davies, S. E., MURCH, S. H., Derkx, B., Heuschkel, R. B., & Fell, J. M. E. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02002.x · Cited by 125
Wright, R., & Truelove, S. (1966) · Digestive Diseases and Sciences · doi:10.1007/bf02233941 · Cited by 125
Olaison, G., Sjödahl, R. I., & Tagesson, C. (1990) · Gut · doi:10.1136/gut.31.3.325 · Cited by 124
Hanai, H., Takeuchi, K., Iida, T., Kashiwagi, N., Saniabadi, A. R., Matsushita, I., Sato, Y., Kasuga, N., & Nakamura, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000042243.47279.87 · Cited by 122
Efthymiou, A., Viazis, N., Mantzaris, G. J., Papadimitriou, N., Tzourmakliotis, D., Raptis, S., & Karamanolis, D. G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20509 · Cited by 118
Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?
Sandborn, W. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.053 · Cited by 117
Prantera, C., Kohn, A., Mangiarotti, R., Andreoli, A., & Luzi, C. (1994) · PubMed · Cited by 112
Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis
GROSS, V., Bar–Meir, S., Lavy, A., Mickisch, O., Tulassay, Z., Pronai, L., Kupčinskas, L., Kiudelis, G., Pokrotnieks, J., Kovács, Á., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02743.x · Cited by 103
Campieri, M., Adamo, S., Valpiani, D., D’Arienzo, A., D'Albasio, G., Pitzalis, M. V., Cesari, P., Casetti, T., Castiglione, G. N., Rizzello, F., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01609.x · Cited by 102
Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis
Kamm, M. A., Lichtenstein, G. R., Sandborn, W. J., Schreiber, S., Lees, K., Barrett, K., & Joseph, R. E. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20580 · Cited by 90
Mansfield, J., Giaffer, M. H., Cann, P. A., Mckenna, D., THORNTON, P. C., & Holdsworth, C. D. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01151.x · Cited by 80
Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis
de Lange, T., Larsen, S., & Aabakken, L. (2004) · BMC Gastroenterology · doi:10.1186/1471-230x-4-9 · Cited by 76
Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
Arnott, I. D., Watts, D., & Ghosh, S. K. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01242.x · Cited by 75
Manguso, F., & Balzano, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03349.x · Cited by 69
Malchow, H. A., Gertz, B., & THE CLAFOAM STUDY GROUP (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01199.x · Cited by 54
Review article: recurrence of Crohn's disease after surgery – the need for treatment of new lesions
Rutgeerts, P. J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03056.x · Cited by 42
Review article: can post‐operative recurrence in Crohn's disease be prevented?
Lémann, M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03055.x · Cited by 41
Self-citationEndoscopic healing should be a goal for everyone with ulcerative colitis
Kane, S. V. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20779 · Cited by 13
Effects of natalizumab on gut healing in a phase 3 study of active Crohn's disease therapy (ENACT-1)
Rutgeerts, P., Allison, M. C., Cortot, A., D’Haens, G., Dahlerup, J. F., Hébuterne, X., Lauritsen, K., Löfberg, R., Ochsenkühn, T., Schreiber, S., et al. (2004) · Gastroenterology · Cited by 10
Cited by
European evidence based consensus for endoscopy in inflammatory bowel disease
Annese, V., Daperno, M., Rutter, M. D., Amiot, A., Bossuyt, P., East, J., Ferrante, M., Götz, M., Katsanos, K. H., Kießlich, R., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.09.016 · Cited by 815
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Rutgeerts, P., Van Assche, G., Sandborn, W. J., Wolf, D. C., Geboes, K., Colombel, J., Reinisch, W., Kumar, A., Lazar, A., Camez, A., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.035 · Cited by 580
Self-citationCX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A., Bonneau, R., Scherl, E. J., & Littman, D. R. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140678 · Cited by 383
The role of endoscopy in inflammatory bowel disease
Shergill, A. K., Lightdale, J. R., Bruining, D. H., Acosta, R. D., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Early, D. S., Evans, J. A., Fanelli, R. D., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.10.030 · Cited by 362
Metadata
- Authors
- Pineton de Chambrun, G., Peyrin-Biroulet, L., Lémann, M., & Colombel, J.-F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2009-12-01
- Volume
- 7
- Issue
- 1
- Pages
- 15-29
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2056873984
- Cited by
- 459
- References
- 99
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.